New antirejection drugs anticipated.
T
T
Randall
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011090:Polyenes / Q000627:therapeutic use; D020123:Sirolimus; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D011090:Polyenes; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus